Stock Comparison
INCY vs VRTX
Incyte Corporation and Vertex Pharmaceuticals Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$22.73B
$124.70B
P/E (TTM)
16.1
29.2
Forward P/E
14.6
25.8
Price/Sales
4.2
10.2
Price/Book
4.0
6.4
EV/EBITDA
10.0
24.0
Dividend Yield
—
—
Profitability
Net Margin
26.70%
35.50%
Operating Margin
25.60%
38.10%
Return on Equity
30.80%
24.20%
Return on Assets
13.90%
12.10%
Growth (YoY)
Revenue Growth
20.90%
7.80%
Earnings Growth
83.80%
61.40%
Price & Risk
Beta
0.8
0.3
52-Week High
$115.56
$507.92
52-Week Low
$66.83
$362.50
Analyst Target
$110.26
$548.69
Compare INCY and VRTX your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.